The presence of VHL mutation in tumor cells has been shown to carry a survival benefit for patients with CC-RCC, which could explain the less aggressive nature of the tumors with overexpressed adipophilin ([23, 24] and our study). This evidence concerns the gene VHL and renal cell adenocarcinoma.